John Hoeven bought Exelon Corporation (NASDAQ: EXC)
John Hoeven (R-ND), a U.S. Senator, has disclosed 1 trade in Exelon Corporation (EXC) since 2019, a single purchase, worth an estimated $75K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: John Hoeven bought $50,001 - $100,000 of Exelon Corporation (NASDAQ: EXC) on November 4, 2019. Since that trade, EXC is up +86.71% against the S&P 500 up +160.97%, an outperformance of -74.26%.
Data updated
John Hoeven's EXC trades vs the price
EXC is up +86.71% since John Hoeven bought on November 4, 2019, versus +160.97% for the S&P 500.
Performance since this trade
All John Hoeven EXC trades
John Hoeven & EXC trading FAQ
Is it legal for John Hoeven to trade Exelon Corporation (EXC) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Exelon Corporation (EXC), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did John Hoeven buy EXC?
John Hoeven disclosed a purchase of $50,001 - $100,000 of Exelon Corporation (EXC) on November 4, 2019, according to public STOCK Act filings.
How has EXC performed since John Hoeven's trade?
Since John Hoeven bought EXC on November 4, 2019, the stock is up +86.71%, versus +160.97% for the S&P 500 over the same period, an outperformance of -74.26%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional EXC trades?
Quantellect tracks every disclosed congressional trade in Exelon Corporation (EXC) on the Exelon Corporation congressional trading page, which aggregates filings across all members of Congress.
John Hoeven's EXC tradesAll congressional filings for Exelon CorporationJohn Hoeven's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.